PharmGKB:  The Pharmacogenetics and Pharmacogenomics Knowledge Base
Search PharmGKB:?
 

Important Variant Information for AHR

Submitted by: Ryan Owen (PharmGKB)
Reviewed by: Under Review
Submitted date: January 10th, 2008

There is One Important Variant for AHR.

  1. AHR-R554K:


1. AHR:R554K

Gene HGNC Name: AHR
Variant Summary: Kawajiri et al first identified the R554K variant of AHR, which occurs at a high frequency in the Japanese population; the authors did not observe any association between the R554K variant and the incidence of lung cancer [7550366]. Smart and Daly [10739168] later observed a difference between reference AHR and AHR-R455K in their ability to induce the transcription of CYP1A1 when treated with the AHR substrate 3-methylcholanthrene (MC). One year later, Wong et al [11207035] did not observe the same result when they used 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) as the substrate to active AHR. Wong et al also determined the allele frequency of AHR-R455K in several different populations (see allele frequency table below).

Since those initial reports, most association studies have been negative. AHR-R554K was not found to be associated with Alzheimer's Disease [12852830], bladder cancer [11866883], or interindividual differences in the expression of CYP1A1 [11505220]. A recent functional study found no difference between reference sequence AHR and AHR-R455K in either AHR mRNA or protein expression, although some lower frequency (and far less studied) variants were identified as having reduced AHR protein expression [15860653].
Key PubMed IDs: 7550366 10739168 11207035 15860653
Genomic Variant & GenBank ID: G17265602A on AC_000139
mRNA Variant & GenBank ID: G1661A on NM_001621
Protein Variant & GenBank ID: R554K on NP_001612
dbSNP rs#: rs2066853
GoldenPath Position: chr7:17345635 on hg18
Key Drugs/Substrates: TCDD and MC
Key Phenotypes/Diseases: N/A
Key PharmGKB pathways: N/A
Population Allele Frequency of 554K Reference
Japanese 0.43 7550366
Ivory Coast African
0.57 11207035
African 0.53 11207035
Caribbean African
0.39 11207035
Canadian Chinese
0.32 11207035
Native Indian
0.14 11207035
French Canadian
0.12 11207035
North American (mixed ethnicities)
0.11 11207035
Canadian Inuit
0.09 11207035
German 0.07 11207035
The PGRN is financially supported by grants from NIGMS, NHLBI, NHGRI, NIEHS, NCI, and NLM within the NIH, HHS. PharmGKB is managed at Stanford University. This work is supported by the NIH/NIGMS Pharmacogenetics Research Network and Database (U01GM61374). ©2001-2008 PharmGKB.